• name

  Amunix Pharmaceuticals, Inc.

• homepage url

  amunix.com

• crunchbase url

  amunix-2

• employee count

  51

• sector

  Healthcare & Health Services

• industry

  Biotechnology

Amunix Pharmaceuticals, Inc. is an immuno-oncology company leveraging its proprietary, clinically validated XTEN® and innovative universal protease-releasable masking technology platform, Pro-XTENTM, to discover and develop transformative T-cell engagers (TCE) and cytokine therapies for patients with cancer.